SCHEMBL25798633

SCHEMBL25798633

CCc1nc(-c2ccccc2)nc(-c2cccc(C)c2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.53
DPP4 P27487 1/20 0.51
NR1I3 Q14994 1/20 0.49
L3MBTL1 Q9Y468 4/20 0.48
SMN1; SMN2 Q16637 6/20 0.48
NPC1 O15118 5/20 0.48
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
TDP1 Q9NUW8 3/20 0.47
MAPK1 P28482 2/20 0.47
TSHR P16473 2/20 0.44
HPGD P15428 1/20 0.44
MAPT P10636 2/20 0.43
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
ABCB1 P08183 1/20 0.43
ABCG2 Q9UNQ0 1/20 0.43
HEXA P06865 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4546934 0.88 RAB9A (0.66) RAB9ADPP4NR1I3L3MBTL1SMN1; SMN2
SCHEMBL29712523 0.88 RAB9A (0.66) RAB9ADPP4NR1I3L3MBTL1SMN1; SMN2
SCHEMBL883671 0.88 RAB9A (0.66) RAB9ADPP4NR1I3L3MBTL1SMN1; SMN2
SCHEMBL23775951 0.86 L3MBTL1 (0.47) L3MBTL1KMT2AMEN1HPGDMAPT
SCHEMBL11978708 0.86 L3MBTL1 (0.58) RAB9AL3MBTL1NPC1KMT2AMEN1
SCHEMBL26083938 0.84 PDE4B (0.44) L3MBTL1KMT2AMEN1HPGDMAPT
SCHEMBL19037188 0.84 RAB9A (0.61) RAB9ADPP4NR1I3L3MBTL1SMN1; SMN2
SCHEMBL18267902 0.84 RAB9A (0.61) RAB9ADPP4NR1I3L3MBTL1SMN1; SMN2
SCHEMBL17726137 0.84 RAB9A (0.61) RAB9ADPP4NR1I3L3MBTL1SMN1; SMN2
SCHEMBL2883804 0.84 RAB9A (0.61) RAB9ADPP4NR1I3L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11696501-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-07-04 US disclosed
US-20230125420-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11696501-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, AGO2, AOC2 RAB9A 2992/4885DPP4 4196/4885NR1I3 4025/4885
US-20230125420-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF OR51E2, NFE2L2, ETV6 RAB9A 3450/4885DPP4 2882/4885NR1I3 3789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.